Invesco Ltd. Medpace Holdings, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 565,567 shares of MEDP stock, worth $198 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

565,567

Previous 806,975 29.92%

Holding current value

$198 Million

Previous $332 Million 43.25%

% of portfolio

0.04%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$320.58 - $457.29 $77.4 Million - $110 Million	-241,408 Reduced 29.92%	565,567 $189 Million
Q2 2024 Aug 13, 2024	SELL	$372.0 - $424.34 $3.28 Million - $3.75 Million	-8,826 Reduced 1.08%	806,975 $332 Million
Q1 2024 May 14, 2024	BUY	$284.87 - $413.31 $26.4 Million - $38.3 Million	92,563 Added 12.8%	815,801 $330 Million
Q4 2023 Feb 12, 2024	BUY	$227.52 - $312.68 $25.3 Million - $34.8 Million	111,338 Added 18.2%	723,238 $222 Million
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $57.7 Million - $69.5 Million	246,775 Added 67.59%	611,900 $148 Million
Q2 2023 Aug 11, 2023	SELL	$187.26 - $240.17 $3.55 Million - $4.56 Million	-18,966 Reduced 4.94%	365,125 $87.7 Million
Q1 2023 May 12, 2023	SELL	$174.31 - $239.52 $36.2 Million - $49.7 Million	-207,654 Reduced 35.09%	384,091 $72.2 Million
Q4 2022 Feb 13, 2023	SELL	$153.06 - $226.57 $21.2 Million - $31.4 Million	-138,516 Reduced 18.97%	591,745 $126 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $9.12 Million - $11.5 Million	-62,822 Reduced 7.92%	730,261 $115 Million
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $13.1 Million - $17 Million	-100,941 Reduced 11.29%	793,083 $119 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $12.8 Million - $19.7 Million	-91,906 Reduced 9.32%	894,024 $146 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $10.6 Million - $13.2 Million	57,837 Added 6.23%	985,930 $215 Million
Q3 2021 Nov 15, 2021	BUY	$170.18 - $198.21 $102,448 - $119,322	602 Added 0.06%	928,093 $176 Million
Q2 2021 Aug 17, 2021	BUY	$158.62 - $194.3 $4.48 Million - $5.49 Million	28,274 Added 3.14%	927,491 $164 Million
Q1 2021 May 17, 2021	BUY	$132.02 - $168.26 $7.32 Million - $9.33 Million	55,437 Added 6.57%	899,217 $148 Million
Q4 2020 Feb 16, 2021	BUY	$109.38 - $149.19 $1.03 Million - $1.41 Million	9,447 Added 1.13%	843,780 $117 Million
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $8.03 Million - $11.3 Million	86,433 Added 11.56%	834,333 $93.2 Million
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $12.4 Million - $17.5 Million	182,434 Added 32.26%	747,900 $69.6 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $1.96 Million - $3.23 Million	-31,692 Reduced 5.31%	565,466 $41.5 Million
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $1.88 Million - $2.27 Million	26,827 Added 4.7%	597,158 $50.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $1.46 Million - $2.01 Million	-23,423 Reduced 3.94%	570,331 $47.9 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $14 Million - $17.1 Million	260,980 Added 78.43%	593,754 $38.8 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $4.99 Million - $7.13 Million	-101,051 Reduced 23.29%	332,774 $19.6 Million
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $20.4 Million - $27.8 Million	433,825 New	433,825 $23 Million

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account